Share Class | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
Class A* | $110 | 1.03% |
* |
During the period, fees were waived and/or expenses reimbursed pursuant to an agreement with the Fund’s investment adviser, BNY Mellon Investment Adviser, Inc. If this agreement is not extended in the future, expenses could be higher.
|
Not FDIC Insured. Not Bank-Guaranteed. May Lose Value |
Class A Shares | 1YR | 5YR | 10YR | |||
with Maximum Sales Charge - 5.75% | 6.20% | 14.03% | 12.05% | |||
without Sales Charge | 12.69% | 15.40% | 12.71% | |||
Russell 1000® Index (broad-based index)* | 18.11% | 16.54% | 12.71% | |||
Russell 1000® Growth Index | 19.75% | 19.71% | 16.01% |
*
|
In accordance with regulatory changes requiring the Fund’s primary benchmark to represent the overall applicable market, the Fund’s primary prospectus benchmark changed to the indicated benchmark effective as of February 28, 2025.
|
Fund Size (Millions) |
Number of Holdings |
Total Advisory Fee Paid During Period |
Annual Portfolio Turnover |
$1,602 | 52 | $12,241,650 | 27.94% |
Not FDIC Insured. Not Bank-Guaranteed. May Lose Value |
Not FDIC Insured. Not Bank-Guaranteed. May Lose Value |
Share Class | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
Class C* | $189 | 1.78% |
* |
During the period, fees were waived and/or expenses reimbursed pursuant to an agreement with the Fund’s investment adviser, BNY Mellon Investment Adviser, Inc. If this agreement is not extended in the future, expenses could be higher.
|
Not FDIC Insured. Not Bank-Guaranteed. May Lose Value |
Class C Shares | 1YR | 5YR | 10YR | |||
with Maximum Deferred Sales Charge - 1.00% | 10.84% |
**
|
14.52% | 11.87% | ||
without Deferred Sales Charge | 11.84% | 14.52% | 11.87% | |||
Russell 1000® Index (broad-based index)* | 18.11% | 16.54% | 12.71% | |||
Russell 1000® Growth Index | 19.75% | 19.71% | 16.01% |
*
|
In accordance with regulatory changes requiring the Fund’s primary benchmark to represent the overall applicable market, the Fund’s primary prospectus benchmark changed to the indicated benchmark effective as of February 28, 2025.
|
**
|
The maximum contingent deferred sales charge for Class C shares is 1.00% for shares redeemed within one year of the date purchased.
|
Fund Size (Millions) |
Number of Holdings |
Total Advisory Fee Paid During Period |
Annual Portfolio Turnover |
$1,602 | 52 | $12,241,650 | 27.94% |
Not FDIC Insured. Not Bank-Guaranteed. May Lose Value |
Not FDIC Insured. Not Bank-Guaranteed. May Lose Value |
Share Class | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
Class I* | $83 | 0.78% |
* |
During the period, fees were waived and/or expenses reimbursed pursuant to an agreement with the Fund’s investment adviser, BNY Mellon Investment Adviser, Inc. If this agreement is not extended in the future, expenses could be higher.
|
Not FDIC Insured. Not Bank-Guaranteed. May Lose Value |
Share Class | 1YR | 5YR | 10YR | |||
Class I | 12.96% | 15.68% | 13.00% | |||
Russell 1000® Index (broad-based index)* | 18.11% | 16.54% | 12.71% | |||
Russell 1000® Growth Index | 19.75% | 19.71% | 16.01% |
*
|
In accordance with regulatory changes requiring the Fund’s primary benchmark to represent the overall applicable market, the Fund’s primary prospectus benchmark changed to the indicated benchmark effective as of February 28, 2025.
|
Fund Size (Millions) |
Number of Holdings |
Total Advisory Fee Paid During Period |
Annual Portfolio Turnover |
$1,602 | 52 | $12,241,650 | 27.94% |
Not FDIC Insured. Not Bank-Guaranteed. May Lose Value |
Not FDIC Insured. Not Bank-Guaranteed. May Lose Value |
Share Class | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
Class Y* | $83 | 0.78% |
* |
During the period, fees were waived and/or expenses reimbursed pursuant to an agreement with the Fund’s investment adviser, BNY Mellon Investment Adviser, Inc. If this agreement is not extended in the future, expenses could be higher.
|
Not FDIC Insured. Not Bank-Guaranteed. May Lose Value |
Share Class | 1YR | 5YR | 10YR | |||
Class Y | 13.01% | 15.68% | 13.02% | |||
Russell 1000® Index (broad-based index)* | 18.11% | 16.54% | 12.71% | |||
Russell 1000® Growth Index | 19.75% | 19.71% | 16.01% |
*
|
In accordance with regulatory changes requiring the Fund’s primary benchmark to represent the overall applicable market, the Fund’s primary prospectus benchmark changed to the indicated benchmark effective as of February 28, 2025.
|
Fund Size (Millions) |
Number of Holdings |
Total Advisory Fee Paid During Period |
Annual Portfolio Turnover |
$1,602 | 52 | $12,241,650 | 27.94% |
Not FDIC Insured. Not Bank-Guaranteed. May Lose Value |
Not FDIC Insured. Not Bank-Guaranteed. May Lose Value |
Share Class | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
Class Z* | $88 | 0.83% |
* |
During the period, fees were waived and/or expenses reimbursed pursuant to an agreement with the Fund’s investment adviser, BNY Mellon Investment Adviser, Inc. If this agreement is not extended in the future, expenses could be higher.
|
Not FDIC Insured. Not Bank-Guaranteed. May Lose Value |
Share Class | 1YR | 5YR | 10YR | |||
Class Z | 12.91% | 15.62% | 12.94% | |||
Russell 1000® Index (broad-based index)* | 18.11% | 16.54% | 12.71% | |||
Russell 1000® Growth Index | 19.75% | 19.71% | 16.01% |
*
|
In accordance with regulatory changes requiring the Fund’s primary benchmark to represent the overall applicable market, the Fund’s primary prospectus benchmark changed to the indicated benchmark effective as of February 28, 2025.
|
Fund Size (Millions) |
Number of Holdings |
Total Advisory Fee Paid During Period |
Annual Portfolio Turnover |
$1,602 | 52 | $12,241,650 | 27.94% |
Not FDIC Insured. Not Bank-Guaranteed. May Lose Value |
Not FDIC Insured. Not Bank-Guaranteed. May Lose Value |
Item 2. | Code of Ethics. |
The Registrant has adopted a code of ethics that applies to the Registrant's principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. There have been no amendments to, or waivers in connection with, the Code of Ethics during the period covered by this Report.
Item 3. | Audit Committee Financial Expert. |
The Registrant's Board has determined that Gina D. France, a member of the Audit Committee of the Board, is an audit committee financial expert as defined by the Securities and Exchange Commission (the "SEC"). Ms. France is "independent" as defined by the SEC for purposes of audit committee financial expert determinations.
Item 4. | Principal Accountant Fees and Services. |
(a) Audit Fees. The aggregate fees billed for each of the last two fiscal years (the "Reporting Periods") for professional services rendered by the Registrant's principal accountant (the "Auditor") for the audit of the Registrant's annual financial statements or services that are normally provided by the Auditor in connection with the statutory and regulatory filings or engagements for the Reporting Periods, were $36,986 in 2024 and $37,725 in 2025.
(b) Audit-Related Fees. The aggregate fees billed in the Reporting Periods for assurance and related services by the Auditor that are reasonably related to the performance of the audit of the Registrant's financial statements and are not reported under paragraph (a) of this Item 4 were $7,430 in 2024 and $7,479 in 2025. These services consisted of one or more of the following: (i) agreed upon procedures related to compliance with Internal Revenue Code section 817(h), (ii) security counts required by Rule 17f-2 under the Investment Company Act of 1940, as amended, (iii) advisory services as to the accounting or disclosure treatment of Registrant transactions or events and (iv) advisory services to the accounting or disclosure treatment of the actual or potential impact to the Registrant of final or proposed rules, standards or interpretations by the Securities and Exchange Commission, the Financial Accounting Standards Boards or other regulatory or standard-setting bodies.
The aggregate fees billed in the Reporting Periods for non-audit assurance and related services by the Auditor to the Registrant's investment adviser (not including any sub-investment adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any entity controlling, controlled by or under common control with the investment adviser that provides ongoing services to the Registrant ("Service Affiliates"), that were reasonably related to the performance of the annual audit of the Service Affiliate, which required pre-approval by the Audit Committee were $0 in 2024 and $0 in 2025.
(c) Tax Fees. The aggregate fees billed in the Reporting Periods for professional services rendered by the Auditor for tax compliance, tax advice, and tax planning ("Tax Services") were $4,763 in 2024 and $4,763 in 2025. These services consisted of: (i) review or preparation of U.S. federal, state, local and excise tax returns; (ii) U.S. federal, state and local tax planning, advice and assistance regarding statutory, regulatory or administrative developments; (iii) tax advice regarding tax qualification matters and/or treatment of various financial instruments held or proposed to be acquired or held, and (iv) determination of Passive Foreign Investment Companies. The aggregate fees billed in the Reporting Periods for Tax Services by the Auditor to Service Affiliates, which required pre-approval by the Audit Committee were $7,082 in 2024 and $7,439 in 2025.
(d) All Other Fees. The aggregate fees billed in the Reporting Periods for products and services provided by the Auditor, other than the services reported in paragraphs (a) through (c) of this Item, were $6,932 in
2024 and $7,767 in 2025. These services consisted of a review of the Registrant's anti-money laundering program.
The aggregate fees billed in the Reporting Periods for Non-Audit Services by the Auditor to Service Affiliates, other than the services reported in paragraphs (b) through (c) of this Item, which required pre-approval by the Audit Committee, were $0 in 2024 and $0 in 2025.
(e)(1) Audit Committee Pre-Approval Policies and Procedures. The Registrant's Audit Committee has established policies and procedures (the "Policy") for pre-approval (within specified fee limits) of the Auditor's engagements for non-audit services to the Registrant and Service Affiliates without specific case-by-case consideration. The pre-approved services in the Policy can include pre-approved audit services, pre-approved audit-related services, pre-approved tax services and pre-approved all other services. Pre-approval considerations include whether the proposed services are compatible with maintaining the Auditor's independence. Pre-approvals pursuant to the Policy are considered annually.
(e)(2) Note. None of the services described in paragraphs (b) through (d) of this Item 4 were approved by the Audit Committee pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.
(f) None of the hours expended on the principal accountant's engagement to audit the registrant's financial statements for the most recent fiscal year were attributed to work performed by persons other than the principal accountant's full-time, permanent employees.
Non-Audit Fees. The aggregate non-audit fees billed by the Auditor for services rendered to the Registrant, and rendered to Service Affiliates, for the Reporting Periods were $1,858,269 in 2024 and $1,402,909 in 2025.
Auditor Independence. The Registrant's Audit Committee has considered whether the provision of non-audit services that were rendered to Service Affiliates, which were not pre-approved (not requiring pre-approval), is compatible with maintaining the Auditor's independence.
(i) | Not applicable. |
(j) | Not applicable. |
Item 5. | Audit Committee of Listed Registrants. |
Not applicable.
Item 6. | Investments. |
Not applicable.
Class
|
Ticker
|
A
|
DWOAX
|
C
|
DWOCX
|
I
|
DWOIX
|
Y
|
DRYQX
|
Z
|
DREQX
|
3
| |
3
| |
6
| |
7
| |
8
| |
10
| |
15
| |
21
| |
22
| |
23
| |
24
| |
25
| |
26
|
Description
|
|
|
|
Shares
|
Value
($) |
Common
Stocks — 99.5% | |||||
Capital
Goods — 9.8% | |||||
AMETEK,
Inc. |
|
|
|
162,492
|
30,759,736
|
Axon
Enterprise, Inc. (a)
|
|
|
|
25,489
|
13,469,662
|
Builders
FirstSource, Inc. (a)
|
|
|
|
83,338
|
11,583,149
|
Howmet
Aerospace, Inc. |
|
|
|
128,608
|
17,567,853
|
Hubbell,
Inc. |
|
|
|
67,782
|
25,187,113
|
Ingersoll
Rand, Inc. |
|
|
|
290,077
|
24,592,728
|
Trane
Technologies PLC |
|
|
|
64,675
|
22,875,547
|
Vertiv
Holdings Co., Cl. A |
|
|
|
109,353
|
10,407,125
|
|
|
|
|
|
156,442,913
|
Commercial
& Professional Services — .7% | |||||
Veralto
Corp. |
|
|
|
120,383
|
12,009,408
|
Consumer
Discretionary Distribution & Retail — 10.8% | |||||
Amazon.com,
Inc. (a)
|
|
|
|
740,033
|
157,094,205
|
Chewy,
Inc., Cl. A (a)
|
|
|
|
444,959
|
16,579,173
|
|
|
|
|
|
173,673,378
|
Consumer
Durables & Apparel — 1.0% | |||||
Lululemon
Athletica, Inc. (a)
|
|
|
|
41,792
|
15,279,573
|
Consumer
Services — .9% | |||||
Planet
Fitness, Inc., Cl. A (a)
|
|
|
|
158,084
|
14,630,674
|
Energy
— 2.0% | |||||
EQT
Corp. |
|
|
|
559,425
|
26,947,502
|
Venture
Global, Inc., Cl. A (a)
|
|
|
|
358,817
|
5,414,549
|
|
|
|
|
|
32,362,051
|
Financial
Services — 1.4% | |||||
Block,
Inc. (a)
|
|
|
|
342,118
|
22,340,305
|
Health
Care Equipment & Services — 6.1% | |||||
Alcon
AG |
|
|
|
131,076
|
12,124,530
|
Align
Technology, Inc. (a)
|
|
|
|
98,486
|
18,419,837
|
Boston
Scientific Corp. (a)
|
|
|
|
149,817
|
15,549,506
|
Dexcom,
Inc. (a)
|
|
|
|
273,812
|
24,196,766
|
Intuitive
Surgical, Inc. (a)
|
|
|
|
48,431
|
27,758,228
|
|
|
|
|
|
98,048,867
|
Household
& Personal Products — .5% | |||||
The
Estee Lauder Companies, Inc., Cl. A |
|
|
|
104,635
|
7,524,303
|
Media
& Entertainment — 13.7% | |||||
Alphabet,
Inc., Cl. C |
|
|
|
754,584
|
129,954,457
|
Netflix,
Inc. (a)
|
|
|
|
30,484
|
29,891,391
|
Pinterest,
Inc., Cl. A (a)
|
|
|
|
569,897
|
21,074,791
|
Reddit,
Inc., Cl. A (a)
|
|
|
|
126,900
|
20,529,882
|
The
Walt Disney Company |
|
|
|
151,689
|
17,262,208
|
|
|
|
|
|
218,712,729
|
Pharmaceuticals,
Biotechnology & Life Sciences — 6.5% | |||||
BioNTech
SE, ADR (a)
|
|
|
|
70,134
|
7,919,531
|
Bio-Techne
Corp. |
|
|
|
208,480
|
12,873,640
|
Danaher
Corp. |
|
|
|
56,629
|
11,765,241
|
Illumina,
Inc. (a)
|
|
|
|
163,314
|
14,492,484
|
Natera,
Inc. (a)
|
|
|
|
50,327
|
7,830,378
|
Repligen
Corp. (a)
|
|
|
|
82,805
|
13,187,524
|
Description
|
|
|
|
Shares
|
Value
($) |
Common
Stocks — 99.5% (continued) | |||||
Pharmaceuticals,
Biotechnology & Life Sciences — 6.5% (continued) | |||||
Sarepta
Therapeutics, Inc. (a)
|
|
|
|
155,784
|
16,629,942
|
Zoetis,
Inc. |
|
|
|
112,406
|
18,798,780
|
|
|
|
|
|
103,497,520
|
Real
Estate Management & Development — 2.1% | |||||
CoStar
Group, Inc. (a)
|
|
|
|
442,450
|
33,736,812
|
Semiconductors
& Semiconductor Equipment — 16.5% | |||||
Broadcom,
Inc. |
|
|
|
182,309
|
36,357,884
|
Micron
Technology, Inc. |
|
|
|
194,623
|
18,222,551
|
NVIDIA
Corp. |
|
|
|
1,679,365
|
209,786,276
|
|
|
|
|
|
264,366,711
|
Software
& Services — 15.7% | |||||
CrowdStrike
Holdings, Inc., Cl. A (a)
|
|
|
|
35,643
|
13,888,651
|
Datadog,
Inc., Cl. A (a)
|
|
|
|
72,418
|
8,440,318
|
HubSpot,
Inc. (a)
|
|
|
|
35,760
|
25,889,882
|
Microsoft
Corp. |
|
|
|
322,732
|
128,121,377
|
MongoDB,
Inc. (a)
|
|
|
|
38,984
|
10,425,491
|
ServiceNow,
Inc. (a)
|
|
|
|
19,739
|
18,352,533
|
Shopify,
Inc., Cl. A (a)
|
|
|
|
287,708
|
32,223,296
|
Synopsys,
Inc. (a)
|
|
|
|
32,420
|
14,825,018
|
|
|
|
|
|
252,166,566
|
Technology
Hardware & Equipment — 10.2% | |||||
Apple,
Inc. |
|
|
|
645,368
|
156,075,797
|
Pure
Storage, Inc., Cl. A (a)
|
|
|
|
139,616
|
7,325,652
|
|
|
|
|
|
163,401,449
|
Transportation
— 1.0% | |||||
Uber
Technologies, Inc. (a)
|
|
|
|
220,072
|
16,727,673
|
Utilities
— .6% | |||||
Constellation
Energy Corp. |
|
|
|
37,095
|
9,293,967
|
Total
Common Stocks
(cost
$735,414,537) |
|
|
|
|
1,594,214,899
|
|
|
1-Day
Yield
(%) |
|
|
|
Investment
Companies — .9% | |||||
Registered
Investment Companies — .9% | |||||
Dreyfus
Institutional Preferred Government Plus Money Market Fund, Institutional
Shares(b)
(cost
$14,513,948) |
|
4.43
|
|
14,513,948
|
14,513,948
|
Total
Investments (cost $749,928,485)
|
|
100.4%
|
1,608,728,847
| ||
Liabilities,
Less Cash and Receivables |
|
(.4%)
|
(6,439,112)
| ||
Net
Assets |
100.0%
|
1,602,289,735
|
ADR—American
Depositary Receipt |
(a)
|
Non-income
producing security. |
(b)
|
Investment
in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment
company’s
prospectus.
|
Affiliated
Issuers | |||||
Description
|
Value
($)
2/29/2024
|
Purchases
($)†
|
Sales
($) |
Value
($)
2/28/2025
|
Dividends/
Distributions
($) |
Registered
Investment Companies - .9% | |||||
Dreyfus
Institutional Preferred Government Plus Money
Market
Fund, Institutional Shares - .9% |
45,689,335
|
333,138,744
|
(364,314,131)
|
14,513,948
|
1,371,406
|
Investment
of Cash Collateral for Securities Loaned - .0% | |||||
Dreyfus
Institutional Preferred Government Plus Money
Market
Fund, Institutional Shares - .0% |
975,000
|
155,286,986
|
(156,261,986)
|
-
|
54,387††
|
Total
- .9% |
46,664,335
|
488,425,730
|
(520,576,117)
|
14,513,948
|
1,425,793
|
†
|
Includes
reinvested dividends/distributions. |
††
|
Represents
securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment
expenses, and
other
payments to and from borrowers of securities. |
|
Cost
|
Value
|
Assets
($): |
|
|
Investments
in securities—See Statement of Investments: |
|
|
Unaffiliated
issuers |
735,414,537
|
1,594,214,899
|
Affiliated
issuers |
14,513,948
|
14,513,948
|
Cash
|
|
3,022,509
|
Dividends
and securities lending income receivable |
|
617,645
|
Receivable
for shares of Common Stock subscribed |
|
31,120
|
Prepaid
expenses |
|
72,235
|
|
|
1,612,472,356
|
Liabilities
($): |
|
|
Due
to BNY Mellon Investment Adviser, Inc. and affiliates—Note
3(c)
|
|
1,124,378
|
Payable
for investment securities purchased |
|
8,024,685
|
Payable
for shares of Common Stock redeemed |
|
812,619
|
Directors’
fees and expenses payable |
|
34,000
|
Other
accrued expenses |
|
186,939
|
|
|
10,182,621
|
Net
Assets ($) |
|
1,602,289,735
|
Composition
of Net Assets ($): |
|
|
Paid-in
capital |
|
672,220,557
|
Total
distributable earnings (loss) |
|
930,069,178
|
Net
Assets ($) |
|
1,602,289,735
|
Net
Asset Value Per Share |
Class
A |
Class
C |
Class
I |
Class
Y |
Class
Z |
Net
Assets ($) |
697,259,198
|
3,373,347
|
181,704,466
|
87,082,196
|
632,870,528
|
Shares
Outstanding |
36,280,649
|
224,956
|
9,292,016
|
4,470,033
|
31,419,355
|
Net
Asset Value Per Share ($) |
19.22
|
15.00
|
19.55
|
19.48
|
20.14
|
|
|
Investment
Income ($): |
|
Income:
|
|
Cash
dividends (net of $14,956 foreign taxes withheld at source): |
|
Unaffiliated
issuers |
5,239,338
|
Affiliated
issuers |
1,371,406
|
Affiliated
income net of rebates from securities lending—Note
1(c)
|
54,387
|
Interest
|
2,351
|
Total
Income |
6,667,482
|
Expenses:
|
|
Management
fee—Note 3(a)
|
12,429,949
|
Shareholder
servicing costs—Note 3(c)
|
2,804,439
|
Directors’
fees and expenses—Note 3(d)
|
159,015
|
Professional
fees |
106,593
|
Registration
fees |
92,636
|
Prospectus
and shareholders’ reports |
87,874
|
Loan
commitment fees—Note 2 |
31,593
|
Distribution
Plan fees—Note 3(c)
|
29,114
|
Chief
Compliance Officer fees—Note 3(c)
|
27,940
|
Custodian
fees—Note 3(c)
|
23,418
|
Interest
expense—Note 2 |
209
|
Miscellaneous
|
69,088
|
Total
Expenses |
15,861,868
|
Less—reduction
in expenses due to undertaking—Note 3(a)
|
(748,081)
|
Less—reduction
in fees due to earnings credits—Note 3(c)
|
(11,404)
|
Net
Expenses |
15,102,383
|
Net
Investment (Loss) |
(8,434,901)
|
Realized
and Unrealized Gain (Loss) on Investments—Note 4 ($):
|
|
Net
realized gain (loss) on investments |
172,629,039
|
Net
change in unrealized appreciation (depreciation) on investments |
35,500,135
|
Net
Realized and Unrealized Gain (Loss) on Investments |
208,129,174
|
Net
Increase in Net Assets Resulting from Operations |
199,694,273
|
|
Year
Ended February 28/29, | |
|
2025
|
2024
|
Operations
($): |
|
|
Net
investment (loss) |
(8,434,901)
|
(4,358,445)
|
Net
realized gain (loss) on investments |
172,629,039
|
18,406,253
|
Net
change in unrealized appreciation (depreciation) on investments |
35,500,135
|
447,125,367
|
Net
Increase (Decrease) in Net Assets Resulting from Operations |
199,694,273
|
461,173,175
|
Distributions
($): |
|
|
Distributions
to shareholders: |
|
|
Class
A |
(27,291,802)
|
(24,071,358)
|
Class
C |
(177,598)
|
(217,936)
|
Class
I |
(7,024,605)
|
(6,731,869)
|
Class
Y |
(3,768,277)
|
(2,996,818)
|
Class
Z |
(23,736,376)
|
(20,853,019)
|
Total
Distributions |
(61,998,658)
|
(54,871,000)
|
Capital
Stock Transactions ($): |
|
|
Net
proceeds from shares sold: |
|
|
Class
A |
12,082,825
|
12,857,302
|
Class
C |
392,839
|
526,467
|
Class
I |
34,249,233
|
51,626,593
|
Class
Y |
9,661,187
|
36,668,432
|
Class
Z |
1,434,644
|
1,063,056
|
Distributions
reinvested: |
|
|
Class
A |
25,927,993
|
22,817,381
|
Class
C |
148,581
|
191,291
|
Class
I |
6,180,174
|
5,576,577
|
Class
Y |
1,751,745
|
1,201,885
|
Class
Z |
22,544,659
|
19,783,760
|
Cost
of shares redeemed: |
|
|
Class
A |
(77,567,102)
|
(77,887,888)
|
Class
C |
(1,896,244)
|
(1,749,854)
|
Class
I |
(56,397,784)
|
(65,082,606)
|
Class
Y |
(32,228,933)
|
(27,286,671)
|
Class
Z |
(71,183,033)
|
(46,369,051)
|
Increase
(Decrease) in Net Assets from Capital Stock Transactions |
(124,899,216)
|
(66,063,326)
|
Total
Increase (Decrease) in Net Assets |
12,796,399
|
340,238,849
|
Net
Assets ($): |
|
|
Beginning
of Period |
1,589,493,336
|
1,249,254,487
|
End
of Period |
1,602,289,735
|
1,589,493,336
|
|
Year
Ended February 28/29, | |
|
2025
|
2024
|
Capital
Share Transactions (Shares): |
|
|
Class
A(a),(b)
|
|
|
Shares
sold |
630,654
|
838,815
|
Shares
issued for distributions reinvested |
1,247,738
|
1,497,114
|
Shares
redeemed |
(4,016,087)
|
(5,151,873)
|
Net
Increase (Decrease) in Shares Outstanding |
(2,137,695)
|
(2,815,944)
|
Class
C(a)
|
|
|
Shares
sold |
25,249
|
42,194
|
Shares
issued for distributions reinvested |
9,149
|
15,719
|
Shares
redeemed |
(126,616)
|
(145,378)
|
Net
Increase (Decrease) in Shares Outstanding |
(92,218)
|
(87,465)
|
Class
I(b)
|
|
|
Shares
sold |
1,758,471
|
3,380,562
|
Shares
issued for distributions reinvested |
292,484
|
361,226
|
Shares
redeemed |
(2,923,328)
|
(4,239,088)
|
Net
Increase (Decrease) in Shares Outstanding |
(872,373)
|
(497,300)
|
Class
Y(b)
|
|
|
Shares
sold |
484,460
|
2,391,786
|
Shares
issued for distributions reinvested |
83,218
|
78,051
|
Shares
redeemed |
(1,642,240)
|
(1,828,692)
|
Net
Increase (Decrease) in Shares Outstanding |
(1,074,562)
|
641,145
|
Class
Z(b)
|
|
|
Shares
sold |
69,657
|
67,490
|
Shares
issued for distributions reinvested |
1,035,534
|
1,244,865
|
Shares
redeemed |
(3,522,913)
|
(2,947,215)
|
Net
Increase (Decrease) in Shares Outstanding |
(2,417,722)
|
(1,634,860)
|
(a)
|
During
the period ended February 28, 2025, 1,485 Class C shares representing $22,630 were automatically converted to 1,173 Class A shares and
during the
period
ended February 29, 2024, 5,269 Class C shares representing $62,921 were automatically converted to 4,223 Class A shares.
|
(b)
|
During
the period ended February 28, 2025, 6,450 Class A shares representing $121,437 were exchanged for 6,930 Class I shares,
19,681 Class Y shares representing $425,106 were exchanged for 19,608 Class I shares
and 7,545 Class Z shares representing $147,361 were exchanged
for
7,764 Class I shares. During the period ended February 29, 2024, 73,017 Class Y shares representing $1,118,365 were exchanged for 72,755
Class I shares,
53,630
Class Z shares representing $866,180 were exchanged for 55,915 Class A shares, 19,642 Class Z shares representing $311,332 were exchanged
for
20,203 Class I shares and 3,672 Class A shares representing $64,120 were exchanged for 3,623 Class I shares. |
|
Year
Ended February 28/29, | ||||
Class
A Shares |
2025
|
2024
|
2023
|
2022
|
2021
|
Per
Share Data ($): |
|
|
|
| |
Net
asset value, beginning of period |
17.68
|
13.26
|
18.48
|
20.76
|
14.68
|
Investment
Operations: |
|
|
|
| |
Net
investment (loss)(a)
|
(.12
) |
(.06
) |
(.07
) |
(.12
) |
(.07
) |
Net
realized and unrealized gain (loss) on investments |
2.42
|
5.09
|
(3.19
) |
.90
|
7.76
|
Total
from Investment Operations |
2.30
|
5.03
|
(3.26
) |
.78
|
7.69
|
Distributions:
|
|
|
|
|
|
Dividends
from net realized gain on investments |
(.76
) |
(.61
) |
(1.96
) |
(3.06
) |
(1.61
) |
Net
asset value, end of period |
19.22
|
17.68
|
13.26
|
18.48
|
20.76
|
Total
Return (%)(b)
|
12.69
|
38.69
|
(16.69
) |
2.36
|
53.57
|
Ratios/Supplemental
Data (%): |
|
|
|
| |
Ratio
of total expenses to average net assets |
1.09
|
1.10
|
1.12
|
1.10
|
1.11
|
Ratio
of net expenses to average net assets(c)
|
1.03
(d)
|
1.02
(d)
|
1.03
(d)
|
1.03
|
1.03
|
Ratio
of net investment (loss) to average net assets(c)
|
(.63
)(d)
|
(.43
)(d)
|
(.50
)(d)
|
(.57
) |
(.36
) |
Portfolio
Turnover Rate |
27.94
|
21.26
|
30.98
|
31.62
|
43.02
|
Net
Assets, end of period ($ x 1,000) |
697,259
|
679,099
|
546,838
|
745,223
|
784,451
|
(a)
|
Based
on average shares outstanding. |
(b)
|
Exclusive
of sales charge. |
(c)
|
Amount
inclusive of reductions in expenses pursuant to undertaking. |
(d)
|
Amount
inclusive of reductions in fees due to earnings credits. |
|
Year
Ended February 28/29, | ||||
Class
C Shares |
2025
|
2024
|
2023
|
2022
|
2021
|
Per
Share Data ($): |
|
|
|
| |
Net
asset value, beginning of period |
14.03
|
10.71
|
15.52
|
18.00
|
12.98
|
Investment
Operations: |
|
|
|
| |
Net
investment (loss)(a)
|
(.21
) |
(.14
) |
(.15
) |
(.24
) |
(.17
) |
Net
realized and unrealized gain (loss) on investments |
1.94
|
4.07
|
(2.70
) |
.82
|
6.80
|
Total
from Investment Operations |
1.73
|
3.93
|
(2.85
) |
.58
|
6.63
|
Distributions:
|
|
|
|
|
|
Dividends
from net realized gain on investments |
(.76
) |
(.61
) |
(1.96
) |
(3.06
) |
(1.61
) |
Net
asset value, end of period |
15.00
|
14.03
|
10.71
|
15.52
|
18.00
|
Total
Return (%)(b)
|
11.84
|
37.60
|
(17.31
) |
1.56
|
52.39
|
Ratios/Supplemental
Data (%): |
|
|
|
| |
Ratio
of total expenses to average net assets |
1.93
|
1.93
|
1.92
|
1.86
|
1.87
|
Ratio
of net expenses to average net assets(c)
|
1.78
(d)
|
1.76
(d)
|
1.78
(d)
|
1.78
|
1.78
|
Ratio
of net investment (loss) to average net assets(c)
|
(1.38
)(d)
|
(1.18
)(d)
|
(1.27
)(d)
|
(1.32
) |
(1.10
) |
Portfolio
Turnover Rate |
27.94
|
21.26
|
30.98
|
31.62
|
43.02
|
Net
Assets, end of period ($ x 1,000) |
3,373
|
4,451
|
4,334
|
10,002
|
15,830
|
(a)
|
Based
on average shares outstanding. |
(b)
|
Exclusive
of sales charge. |
(c)
|
Amount
inclusive of reductions in expenses pursuant to undertaking. |
(d)
|
Amount
inclusive of reductions in fees due to earnings credits. |
|
Year
Ended February 28/29, | ||||
Class
I Shares |
2025
|
2024
|
2023
|
2022
|
2021
|
Per
Share Data ($): |
|
|
|
| |
Net
asset value, beginning of period |
17.93
|
13.41
|
18.62
|
20.85
|
14.73
|
Investment
Operations: |
|
|
|
| |
Net
investment (loss)(a)
|
(.07
) |
(.03
) |
(.04
) |
(.07
) |
(.02
) |
Net
realized and unrealized gain (loss) on investments |
2.45
|
5.16
|
(3.21
) |
.90
|
7.79
|
Total
from Investment Operations |
2.38
|
5.13
|
(3.25
) |
.83
|
7.77
|
Distributions:
|
|
|
|
|
|
Dividends
from net investment income |
-
|
-
|
-
|
-
|
(.04
) |
Dividends
from net realized gain on investments |
(.76
) |
(.61
) |
(1.96
) |
(3.06
) |
(1.61
) |
Total
Distributions |
(.76
) |
(.61
) |
(1.96
) |
(3.06
) |
(1.65
) |
Net
asset value, end of period |
19.55
|
17.93
|
13.41
|
18.62
|
20.85
|
Total
Return (%) |
12.96
|
39.01
|
(16.50
) |
2.66
|
53.92
|
Ratios/Supplemental
Data (%): |
|
|
|
| |
Ratio
of total expenses to average net assets |
.84
|
.86
|
.85
|
.82
|
.84
|
Ratio
of net expenses to average net assets(b)
|
.78
(c)
|
.78
(c)
|
.78
(c)
|
.78
|
.78
|
Ratio
of net investment (loss) to average net assets(b)
|
(.38
)(c)
|
(.17
)(c)
|
(.26
)(c)
|
(.32
) |
(.11
) |
Portfolio
Turnover Rate |
27.94
|
21.26
|
30.98
|
31.62
|
43.02
|
Net
Assets, end of period ($ x 1,000) |
181,704
|
182,253
|
142,996
|
253,415
|
284,607
|
(a)
|
Based
on average shares outstanding. |
(b)
|
Amount
inclusive of reductions in expenses pursuant to undertaking. |
(c)
|
Amount
inclusive of reductions in fees due to earnings credits. |
|
Year
Ended February 28/29, | ||||
Class
Y Shares |
2025
|
2024
|
2023
|
2022
|
2021
|
Per
Share Data ($): |
|
|
|
| |
Net
asset value, beginning of period |
17.87
|
13.37
|
18.56
|
20.79
|
14.70
|
Investment
Operations: |
|
|
|
| |
Net
investment (loss)(a)
|
(.07
) |
(.03
) |
(.04
) |
(.07
) |
(.02
) |
Net
realized and unrealized gain (loss) on investments |
2.44
|
5.14
|
(3.19
) |
.90
|
7.76
|
Total
from Investment Operations |
2.37
|
5.11
|
(3.23
) |
.83
|
7.74
|
Distributions:
|
|
|
|
|
|
Dividends
from net investment income |
-
|
-
|
-
|
-
|
(.04
) |
Dividends
from net realized gain on investments |
(.76
) |
(.61
) |
(1.96
) |
(3.06
) |
(1.61
) |
Total
Distributions |
(.76
) |
(.61
) |
(1.96
) |
(3.06
) |
(1.65
) |
Net
asset value, end of period |
19.48
|
17.87
|
13.37
|
18.56
|
20.79
|
Total
Return (%) |
13.01
|
38.90
|
(16.44
) |
2.61
|
53.90
|
Ratios/Supplemental
Data (%): |
|
|
|
| |
Ratio
of total expenses to average net assets |
.79
|
.80
|
.80
|
.78
|
.80
|
Ratio
of net expenses to average net assets |
.78
(b),(c)
|
.78
(b),(c)
|
.78
(b),(c)
|
.78
|
.78
(c)
|
Ratio
of net investment (loss) to average net assets |
(.38
)(b),(c)
|
(.18
)(b),(c)
|
(.29
)(b),(c)
|
(.33
) |
(.10
)(c)
|
Portfolio
Turnover Rate |
27.94
|
21.26
|
30.98
|
31.62
|
43.02
|
Net
Assets, end of period ($ x 1,000) |
87,082
|
99,056
|
65,538
|
285,559
|
371,053
|
(a)
|
Based
on average shares outstanding. |
(b)
|
Amount
inclusive of reductions in fees due to earnings credits. |
(c)
|
Amount
inclusive of reductions in expenses pursuant to undertaking. |
|
Year
Ended February 28/29, | ||||
Class
Z Shares |
2025
|
2024
|
2023
|
2022
|
2021
|
Per
Share Data ($): |
|
|
|
| |
Net
asset value, beginning of period |
18.46
|
13.80
|
19.10
|
21.32
|
15.04
|
Investment
Operations: |
|
|
|
| |
Net
investment (loss)(a)
|
(.09
) |
(.04
) |
(.05
) |
(.08
) |
(.03
) |
Net
realized and unrealized gain (loss) on investments |
2.53
|
5.31
|
(3.29
) |
.92
|
7.95
|
Total
from Investment Operations |
2.44
|
5.27
|
(3.34
) |
.84
|
7.92
|
Distributions:
|
|
|
|
|
|
Dividends
from net investment income |
-
|
-
|
-
|
-
|
(.03
) |
Dividends
from net realized gain on investments |
(.76
) |
(.61
) |
(1.96
) |
(3.06
) |
(1.61
) |
Total
Distributions |
(.76
) |
(.61
) |
(1.96
) |
(3.06
) |
(1.64
) |
Net
asset value, end of period |
20.14
|
18.46
|
13.80
|
19.10
|
21.32
|
Total
Return (%) |
12.91
|
38.92
|
(16.56
) |
2.59
|
53.88
|
Ratios/Supplemental
Data (%): |
|
|
|
| |
Ratio
of total expenses to average net assets |
.86
|
.87
|
.88
|
.84
|
.87
|
Ratio
of net expenses to average net assets(b)
|
.83
(c)
|
.82
(c)
|
.84
(c)
|
.83
|
.83
|
Ratio
of net investment (loss) to average net assets(b)
|
(.43
)(c)
|
(.24
)(c)
|
(.32
)(c)
|
(.37
) |
(.16
) |
Portfolio
Turnover Rate |
27.94
|
21.26
|
30.98
|
31.62
|
43.02
|
Net
Assets, end of period ($ x 1,000) |
632,871
|
624,635
|
489,549
|
656,046
|
688,588
|
(a)
|
Based
on average shares outstanding. |
(b)
|
Amount
inclusive of reductions in expenses pursuant to undertaking. |
(c)
|
Amount
inclusive of reductions in fees due to earnings credits. |
|
Level
1 -
Unadjusted
Quoted
Prices |
Level
2- Other
Significant
Observable
Inputs |
Level
3-
Significant
Unobservable
Inputs
|
Total
|
Assets
($) |
|
|
|
|
Investments
in Securities:†
|
|
|
|
|
Equity
Securities - Common Stocks |
1,594,214,899
|
—
|
—
|
1,594,214,899
|
Investment
Companies |
14,513,948
|
—
|
—
|
14,513,948
|
|
1,608,728,847
|
—
|
—
|
1,608,728,847
|
†
|
See
Statement of Investments for additional detailed categorizations, if any. |
Item 12. | Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies. |
Not applicable.
Item 13. | Portfolio Managers for Closed-End Management Investment Companies. |
Not applicable.
Item 14. | Purchases of Equity Securities By Closed-End Management Investment Companies and Affiliated Purchasers. |
Not applicable.
Item 15. | Submission of Matters to a Vote of Security Holders. |
There have been no material changes to the procedures applicable to Item 15.
Item 16. | Controls and Procedures. |
(a) | The Registrant's principal executive and principal financial officers have concluded, based on their evaluation of the Registrant's disclosure controls and procedures as of a date within 90 days of the filing date of this report, that the Registrant's disclosure controls and procedures are reasonably designed to ensure that information required to be disclosed by the Registrant on Form N-CSR is recorded, processed, summarized and reported within the required time periods and that information required to be disclosed by the Registrant in the reports that it files or submits on Form N-CSR is accumulated and communicated to the Registrant's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. |
(b) | There were no changes to the Registrant's internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Registrant's internal control over financial reporting. |
Item 17. | Disclosure of Securities Lending Activities for Closed-End Management Investment Companies. |
Not applicable.
Item 18. | Recovery of Erroneously Awarded Compensation. |
Not applicable.
Item 19. | Exhibits. |
(a)(1) Code of ethics referred to in Item 2.
(a)(2) | Certifications of principal executive and principal financial officers as required by Rule 30a-2(a) under the Investment Company Act of 1940. |
(a)(3) Not applicable.
(b) | Certification of principal executive and principal financial officers as required by Rule 30a-2(b) under the Investment Company Act of 1940. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
BNY Mellon Research Growth Fund, Inc.
By: /s/ David J. DiPetrillo
David J. DiPetrillo
President (Principal Executive Officer)
Date: April 21, 2025
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
By: /s/ David J. DiPetrillo
David J. DiPetrillo
President (Principal Executive Officer)
Date: April 21, 2025
By: /s/ James Windels
James Windels
Treasurer (Principal Financial Officer)
Date: April 21, 2025
EXHIBIT INDEX
(a)(1) | Code of ethics referred to in Item 2. |
(a)(2) | Certifications of principal executive and principal financial officers as required by Rule 30a-2(a) under the Investment Company Act of 1940. (EX-99.CERT) |
(b) | Certification of principal executive and principal financial officers as required by Rule 30a-2(b) under the Investment Company Act of 1940. (EX-99.906CERT) |
THE BNY MELLON FAMILY OF FUNDS
BNY MELLON FUNDS TRUST
Principal Executive Officer and Senior Financial Officer
Code of Ethics
This code of ethics (the "Code"), adopted by the funds in the BNY Mellon Family of Funds and BNY Mellon Funds Trust (each, a "Fund"), applies to each Fund's Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer or Controller, or other persons performing similar functions, each of whom is listed on Exhibit A (the "Covered Officers"), for the purpose of promoting:
· honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;
· full, fair, accurate, timely and understandable disclosure in reports and documents that the Fund files with, or submits to, the Securities and Exchange Commission (the "SEC") and in other public communications made by the Fund;
· compliance with applicable laws and governmental rules and regulations;
· the prompt internal reporting of violations of the Code to an appropriate person or persons identified in the Code; and
· accountability for adherence to the Code.
Each Covered Officer should adhere to a high standard of business ethics and should be sensitive to situations that may give rise to actual as well as apparent conflicts of interest.
Overview. A "conflict of interest" occurs when a Covered Officer's private interest interferes with the interests of, or his service to, the Fund. For example, a conflict of interest would arise if a Covered Officer, or a member of his family, receives improper personal benefits as a result of his position with the Fund.
Certain conflicts of interest arise out of the relationships between Covered Officers and the Fund and already are subject to conflict of interest provisions in the Investment Company Act of 1940, as amended (the "Investment Company Act"), and the Investment Advisers Act of 1940, as amended (the "Investment Advisers Act"). For example, Covered Officers may not individually engage in certain transactions (such as the purchase or sale of securities or other property) with the Fund because of their status as "affiliated persons" of the Fund. The compliance programs and procedures of the Fund and the Fund's investment adviser (the "Adviser") are designed to prevent, or identify and correct, violations of these provisions. The Code does not, and is not intended to, repeat or replace these programs and procedures, and the circumstances they cover fall outside of the parameters of the Code.
Although typically not presenting an opportunity for improper personal benefit, conflicts arise from, or as a result of, the contractual relationship between the Fund and the Adviser of which the Covered Officers are also officers or employees. As a result, the Code recognizes that the Covered Officers, in the ordinary course of their duties (whether formally for the Fund or for the Adviser, or for both), will be involved in establishing policies and implementing decisions that will have different effects on the Adviser and the Fund. The participation of the Covered Officers in such activities is inherent in the contractual relationship between the Fund and the Adviser and is consistent with the performance by the Covered Officers of their duties as officers of the Fund and, if addressed in conformity with the provisions of the Investment Company Act and the Investment Advisers Act, will be deemed to have been handled ethically. In addition, it is recognized by the Fund's Board that the Covered Officers also may be officers or employees of one or more other investment companies covered by this or other codes of ethics.
Other conflicts of interest are covered by the Code, even if such conflicts of interest are not subject to provisions in the Investment Company Act and the Investment Advisers Act. Covered Officers should keep in mind that the Code cannot enumerate every possible scenario. The overarching principle of the Code is that the personal interest of a Covered Officer should not be placed improperly before the interest of the Fund.
Each Covered Officer must:
· not use his personal influence or personal relationships improperly to influence investment decisions or financial reporting by the Fund whereby the Covered Officer would benefit personally to the detriment of the Fund;
· not cause the Fund to take action, or fail to take action, for the individual personal benefit of the Covered Officer rather than the benefit of the Fund; and
· not retaliate against any employee or Covered Officer for reports of potential violations that are made in good faith.
· Each Covered Officer should familiarize himself with the disclosure requirements generally applicable to the Fund within his area of responsibility;
· each Covered Officer should not knowingly misrepresent, or cause others to misrepresent, facts about the Fund to others, whether within or outside the Fund, including to the Fund's Board members and auditors, and to governmental regulators and self-regulatory organizations;
· each Covered Officer should, to the extent appropriate within his area of responsibility, consult with other officers and employees of the Fund and the Adviser with the goal of promoting full, fair, accurate, timely and understandable disclosure in the reports and documents the Fund files with, or submits to, the SEC and in other public communications made by the Fund; and
· it is the responsibility of each Covered Officer to promote compliance with the standards and restrictions imposed by applicable laws, rules and regulations.
Each Covered Officer must:
· upon adoption of the Code (or thereafter, as applicable, upon becoming a Covered Officer), affirm in writing to the Board that he has received, read, and understands the Code;
· annually thereafter affirm to the Board that he has complied with the requirements of the Code; and
· notify the Adviser's General Counsel (the "General Counsel") promptly if he knows of any violation of the Code. Failure to do so is itself a violation of the Code.
The General Counsel is responsible for applying the Code to specific situations in which questions are presented under it and has the authority to interpret the Code in any particular situation. However, waivers sought by any Covered Officer will be considered by the Fund's Board.
The Fund will follow these procedures in investigating and enforcing the Code:
· the General Counsel will take all appropriate action to investigate any potential violations reported to him;
· if, after such investigation, the General Counsel believes that no violation has occurred, the General Counsel is not required to take any further action;
· any matter that the General Counsel believes is a violation will be reported to the Board;
· if the Board concurs that a violation has occurred, it will consider appropriate action, which may include: review of, and appropriate modifications to, applicable policies and procedures; notification to appropriate personnel of the Adviser or its board; or dismissal of the Covered Officer;
· the Board will be responsible for granting waivers, as appropriate; and
· any waivers of or amendments to the Code, to the extent required, will be disclosed as provided by SEC rules.
The Code shall be the sole code of ethics adopted by the Fund for purposes of Section 406 of the Sarbanes-Oxley Act of 2002 and the rules and forms applicable to registered investment companies thereunder. The Fund's, its principal underwriter's and the Adviser's codes of ethics under Rule 17j-1 under the Investment Company Act and the Adviser's additional policies and procedures, including its Code of Conduct, are separate requirements applying to the Covered Officers and others, and are not part of the Code.
Except as to Exhibit A, the Code may not be amended except in written form, which is specifically approved or ratified by a majority vote of the Fund's Board, including a majority of independent Board members.
All reports and records prepared or maintained pursuant to the Code will be considered confidential and shall be maintained and protected accordingly. Except as otherwise required by law or the Code, such matters shall not be disclosed to anyone other than the appropriate Funds and their counsel, the appropriate Boards (or Committees) and their counsel and the Adviser.
The Code is intended solely for the internal use by the Fund and does not constitute an admission, by or on behalf of the Fund, as to any fact, circumstance, or legal conclusion.
Dated as of: January 14, 2021
Exhibit A
Persons Covered by the Code of Ethics
David J. DiPetrillo |
President |
(Principal Executive Officer, BNY Mellon Family of Funds) |
|
|
|
Patrick T. Crowe |
President |
(Principal Executive Officer, BNY Mellon Funds Trust) |
|
|
|
James M. Windels |
Treasurer |
(Principal Financial and Accounting Officer) |
[EX-99.CERT]—Exhibit (a)(2)
SECTION 302 CERTIFICATION
I, David J. DiPetrillo, certify that:
1. I have reviewed this report on Form N-CSR of BNY Mellon Research Growth Fund, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
By: /s/ David J. DiPetrillo
David J. DiPetrillo
President (Principal Executive Officer)
Date: April 21, 2025
SECTION 302 CERTIFICATION
I, James Windels, certify that:
1. I have reviewed this report on Form N-CSR of BNY Mellon Research Growth Fund, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
By: /s/ James Windels
James Windels
Treasurer (Principal Financial Officer)
Date: April 21, 2025
[EX-99.906CERT]
Exhibit (b)
SECTION 906 CERTIFICATIONS
In connection with this report on Form N-CSR for the Registrant as furnished to the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as applicable; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
By: /s/ David J. DiPetrillo
David J. DiPetrillo
President (Principal Executive Officer)
Date: April 21, 2025
By: /s/ James Windels
James Windels
Treasurer (Principal Financial Officer)
Date: April 21, 2025
This certificate is furnished pursuant to the requirements of Form N-CSR and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.